Apexus Generics Program (AGP) Price
Definition
The Apexus Generics Program (AGP) price represents contracted pricing on multi-sourced generic products available to PVP participants. Apexus negotiates these prices with distributor partners on behalf of 340B covered entities, providing access to competitive generic drug pricing.
AGP prices may be loaded in the 340B and/or WAC purchasing accounts. The program provides manufacturers with full price protections and contracting infrastructure to support covered entity compliance with the GPO Prohibition.
For covered entities subject to the GPO Prohibition, the AGP provides a compliant mechanism for accessing competitive generic pricing without using a traditional GPO arrangement. For all covered entities, AGP pricing represents an additional optimization opportunity for generic drug purchasing.
Frequently Asked Questions
Why Apexus Generics Program (AGP) Price Matters
Generic drugs represent a large portion of prescription volume. AGP pricing can provide additional savings on generics beyond the standard 340B ceiling price. Covered entities should evaluate whether they are accessing available AGP prices.
How Virtue 340B Uses It
Virtue 340B helps covered entities understand and access AGP pricing opportunities as part of our program optimization services.